CIK 0001711279
- Large accelerated filer
Krystal Biotech, Inc.
Sign in to watch- Ticker
- KRYS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 821080209
- Phone
- +1 412-586-5830
- Business address
- 2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
- 4 Shares withheld for taxes President and CEO gave up 30,584 shares (to pay taxes)
- 4 Planned sale Director sold 11,803 shares at an average $275.59 ($3,252,824)
- 4 Planned sale Director sold 60,161 shares at an average $268.44 ($16,149,383)
- 4 Open-market sale Director sold 18,950 shares at an average $261.41 ($4,953,694)
- 4 Planned sale Chief Accounting Officer sold 12,500 shares at an average $272.14 ($3,401,705)
- 4 Planned sale President, R&D sold 50,000 shares at an average $220.15 ($11,007,333)
- 4 Planned sale President and CEO sold 50,000 shares at an average $220.15 ($11,007,447)
- 4 Planned sale President, R&D sold 35,873 shares at an average $150.39 ($5,395,001)
- 4 Planned sale President and CEO sold 35,873 shares at an average $150.39 ($5,395,001)
- 4 Planned sale President, R&D sold 14,127 shares at an average $150.27 ($2,122,835)
- 4 Planned sale President and CEO sold 14,127 shares at an average $150.27 ($2,122,835)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale President, R&D sold 50,000 shares at an average $177.79 ($8,889,525)
- 4 Planned sale President and CEO sold 50,000 shares at an average $177.79 ($8,889,525)
- 4 Planned sale Chief Accounting Officer sold 750 shares at $175.22 ($131,415)
Page 2 of 10 · 186 filings